Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND GATA3, HDR, 2625, ENSG00000107485, MGC5445, MGC5199, MGC2346 AND Diagnosis
26 results:

  • 1. Clinicopathological Features and Prognosis of Gastrointestinal Metastases From Breast Carcinoma: A Clinicopathological Study of 22 Patients.
    Wang S; Li W; Li S; Liu X; Zhang L; Hao C; Meng W; Zhao W; Tong Z
    Int J Surg Pathol; 2023 Sep; 31(6):1075-1084. PubMed ID: 36803140
    [No Abstract]    [Full Text] [Related]  

  • 2. Longitudinal Associations of Former and Current Alcohol Consumption with Psychosocial Outcomes among colorectal cancer Survivors 1-15 Years after diagnosis.
    Révész D; Bours MJL; Weijenberg MP; Mols F
    Nutr Cancer; 2022; 74(9):3109-3117. PubMed ID: 35212245
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [Clinicopathological analysis of lung metastatic tumor].
    Lou N; Niu YR; Yang F; Lu ZH
    Zhonghua Bing Li Xue Za Zhi; 2021 Sep; 50(9):1039-1044. PubMed ID: 34496496
    [No Abstract]    [Full Text] [Related]  

  • 4. Coexpress of GATA-3 and ER in Anorectal and Head and Neck Squamous Cell Carcinoma Mimicking Metastatic Breast cancer.
    Wang Y; Lu S; Amin A; Wang L
    Appl Immunohistochem Mol Morphol; 2021 Jul; 29(6):409-413. PubMed ID: 33264107
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Lesions of anogenital mammary-like glands: Four cases including novel pathologic and immunohistochemical observations.
    Arora K; El-Zaatari ZM; Schwartz MR; Ro JY
    Ann Diagn Pathol; 2020 Aug; 47():151551. PubMed ID: 32592993
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Histological clues to the diagnosis of metastasis to the breast from extramammary malignancies.
    Lee AHS; Hodi Z; Soomro I; Sovani V; Abbas A; Rakha E; Ellis IO
    Histopathology; 2020 Aug; 77(2):303-313. PubMed ID: 32396659
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Primary adenocarcinoma of the bladder lacks mismatch repair deficiency and demonstrates PD-L1 expression in tumor-infiltrating immune cells, with implications in both diagnosis and therapeutics.
    Jones D; Guan JJ; Calagua C; Hansel DE; Epstein JI; Ye H
    Hum Pathol; 2019 Dec; 94():58-63. PubMed ID: 31666198
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Villous Morphology in Urinary Bladder Biopsy: An Approach to diagnosis.
    Mitra S; Ayyanar P; Kaur G
    Int J Surg Pathol; 2020 Feb; 28(1):4-12. PubMed ID: 31409167
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Identification of Prognostic Biomarker Signatures and Candidate Drugs in colorectal cancer: Insights from Systems Biology Analysis.
    Rahman MR; Islam T; Gov E; Turanli B; Gulfidan G; Shahjaman M; Banu NA; Mollah MNH; Arga KY; Moni MA
    Medicina (Kaunas); 2019 Jan; 55(1):. PubMed ID: 30658502
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Immunohistochemical profiles in primary lung cancers and epithelial pulmonary metastases.
    Vidarsdottir H; Tran L; Nodin B; Jirström K; Planck M; Jönsson P; Mattsson JSM; Botling J; Micke P; Brunnström H
    Hum Pathol; 2019 Feb; 84():221-230. PubMed ID: 30389437
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [Transcription factors in tumor diagnosis].
    Moll R
    Pathologe; 2018 Dec; 39(Suppl 2):285-290. PubMed ID: 30298190
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. The Clinical Value of PELP1 for Breast cancer: A Comparison with Multiple cancers and Analysis in Breast cancer Subtypes.
    Wang X; Tsang JYS; Lee MA; Ni YB; Tong JH; Chan SK; Cheung SY; To KF; Tse GM
    Cancer Res Treat; 2019 Apr; 51(2):706-717. PubMed ID: 30134648
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Biomarkers in Urachal cancer and Adenocarcinomas in the Bladder: A Comprehensive Review Supplemented by Own Data.
    Reis H; Krafft U; Niedworok C; Módos O; Herold T; Behrendt M; Al-Ahmadie H; Hadaschik B; Nyirady P; Szarvas T
    Dis Markers; 2018; 2018():7308168. PubMed ID: 29721106
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Symptoms of anxiety and depression among colorectal cancer survivors from the population-based, longitudinal PROFILES Registry: Prevalence, predictors, and impact on quality of life.
    Mols F; Schoormans D; de Hingh I; Oerlemans S; Husson O
    Cancer; 2018 Jun; 124(12):2621-2628. PubMed ID: 29624635
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Changing pathological diagnosis from hyperplastic polyp to sessile serrated adenoma: systematic review and meta-analysis.
    Niv Y
    Eur J Gastroenterol Hepatol; 2017 Dec; 29(12):1327-1331. PubMed ID: 29049128
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Is Type D personality a risk factor for all-cause mortality? A prospective population-based study among 2625 colorectal cancer survivors from the PROFILES registry.
    Schoormans D; Husson O; Denollet J; Mols F
    J Psychosom Res; 2017 May; 96():76-83. PubMed ID: 28545796
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Colon cancer Surgery: A Retrospective Study Based on a Large Administrative Database.
    Saia M; Buja A; Mantoan D; Agresta F; Baldo V
    Surg Laparosc Endosc Percutan Tech; 2016 Dec; 26(6):e126-e131. PubMed ID: 27846172
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Hotspot mutations delineating diverse mutational signatures and biological utilities across cancer types.
    Chen T; Wang Z; Zhou W; Chong Z; Meric-Bernstam F; Mills GB; Chen K
    BMC Genomics; 2016 Jun; 17 Suppl 2(Suppl 2):394. PubMed ID: 27356755
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Differential diagnosis of bladder versus colorectal adenocarcinoma: keratin 7 and gata3 positivity in nuclear ß-catenin-negative glandular tumours defines adenocarcinoma of the bladder.
    Broede A; Oll M; Maurer A; Siegert S; Stoerkel S; Golz R; Schwamborn K; Veeck J; Knuechel R; Gaisa NT;
    J Clin Pathol; 2016 Apr; 69(4):307-12. PubMed ID: 26463756
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Health-related quality of life is associated with physical activity levels among colorectal cancer survivors: a longitudinal, 3-year study of the PROFILES registry.
    Husson O; Mols F; Ezendam NP; Schep G; van de Poll-Franse LV
    J Cancer Surviv; 2015 Sep; 9(3):472-80. PubMed ID: 25573723
    [TBL] [Abstract] [Full Text] [Related]  


    of 2.